Lipid Lowering Therapy, an essential aspect of cardiovascular care, is designed to address and control elevated cholesterol and triglyceride levels within the bloodstream. By employing various medications like statins, fibrates, or cholesterol absorption inhibitors, this therapeutic approach aims to bring about a significant reduction in lipid levels, thereby reducing the risk of cardiovascular diseases, including heart attacks and strokes. The significance of Lipid Lowering Therapy lies in its ability to curtail one of the primary risk factors associated with cardiovascular complications. Regular monitoring of lipid levels and the implementation of personalized treatment plans are key elements in ensuring the effectiveness of Lipid Lowering Therapy. Healthcare professionals tailor interventions based on individual patient profiles, considering factors such as age, medical history, and existing conditions. This personalized approach enhances the precision and success of the therapy, emphasizing its role in holistic cardiovascular management.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine